Latest news
Loading news…
EpiBiologics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. San Mateo, California, United States Founded 2022 11-50 employees For Profit
EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
23
Patents
5
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 29
- Patents granted
- 5
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $848K
Company Info
- Founded
- 2022
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 39
- HQ
- San Mateo, California, United States
- Region
- San Francisco Bay Area, Silicon Valley, West Coast
Signals & Scores
- Heat score
- Low
- Growth score
- High
- Trend (7d)
- 0
- Trend (30d)
- -0.2
- Trend (90d)
- -0.3
- Last leadership hire
- Jul 20, 2023
Key People at EpiBiologics
Chief Executive Officer and President
23
professional contacts at EpiBiologics
Contact execs at EpiBiologics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to EpiBiologics
Loading news…
FAQs about EpiBiologics
People who checked this page also checked these
Browse the full Acquirezy directory.